Skip to content
Important: This site presents data from the FDA Adverse Event Reporting System (FAERS). A report does not mean the drug caused the event. Full disclaimer.

LEVODOPA vs LEVOLEUCOVORIN: Which Drug Is Safer?

Boost Your Natural Energy & Metabolism

Mitolyn — 6 exotic plants to unlock your body's fat-burning power. 90-day guarantee.

Try Mitolyn Now

LEVODOPA vs LEVOLEUCOVORIN: Safety Overview

Metric LEVODOPA LEVOLEUCOVORIN
Total FAERS Reports 6,610 3,168
Deaths Reported 546 421
Death Rate 8.3% 13.3%
Hospitalizations 729 1,413
Average Patient Age 69.3 yrs 64.9 yrs
% Female Patients 42.9% 36.1%
FDA Approval Date Approved Prior to Jan 1, 1982 Apr 29, 2011
Manufacturer Deseret Biologicals, Inc. Hikma Pharmaceuticals USA Inc.
Route ORAL INTRAVENOUS
Marketing Status Discontinued Discontinued